Clinical Trial Update: Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating two doses of mesalazine granules versus placebo for preventing recurrence of diverticulitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diverticulitis

Drugs mentioned

• Mesalazine Granules (mesalazine)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Diverticulitis | Phase 3 | Status: TERMINATED